Search Results

You are looking at 1 - 10 of 123 items for :

  • "thrombosis" x
Clear All
Full access

Michael L. Linenberger

thrombosis and pulmonary embolism: a population-based case-control study . Arch Intern Med 2000 ; 160 : 809 – 815 . 2. Joffe HV Kucher N Tapson VF . Upper-extremity deep vein thrombosis: a prospective registry of 592 patients . Circulation

Full access

Charise Gleason, Ajay Nooka and Sagar Lonial

. 41 Palumbo A Rajkumar SV Dimopoulos MA . Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma . Leukemia 2008 ; 22 : 414 – 423 . 42 Sezer O . Myeloma bone disease: recent advances in biology, diagnosis, and

Full access

Nikolai A. Podoltsev, Mengxin Zhu, Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Amy J. Davidoff, Scott F. Huntington, Smith Giri, Steven D. Gore and Xiaomei Ma

of the age- and sex-matched US population. 2 Patients with ET are at >20% risk for thrombotic complications. 3 , 4 Thus, a major goal of ET treatment is thrombosis prevention. Patients are categorized into high- and low-risk groups based on the

Full access

Cocav A. Engman and Leo R. Zacharski

responsible for the content and editorial decisions regarding this manuscript. References 1. Heit JA Silverstein MD Mohr DN . Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study . Arch Intern

Full access

Christine G. Kohn, Gary H. Lyman, Jan Beyer-Westendorf, Alex C. Spyropoulos, Thomas J. Bunz, William L. Baker, Daniel Eriksson, Anna-Katharina Meinecke and Craig I. Coleman

Although anticoagulation is the cornerstone of management of cancer-associated venous thrombosis (CAT), its use is complicated by patients' higher risk of both recurrent VTE and bleeding complications. 3 , 4 Randomized controlled trials (RCTs) have

Full access

Andrew S. Epstein and Eileen M. O'Reilly

are a major contributor to cancer- and treatment-related morbidity and mortality. Exocrine pancreas cancer is one of the most common malignancies associated with thrombosis, with most modern studies reporting incidence ranging from 5% to 27%. 1 – 6

Full access

Ang Li, Qian Wu, Suhong Luo, Greg S. Warnick, Neil A. Zakai, Edward N. Libby, Brian F. Gage, David A. Garcia, Gary H. Lyman and Kristen M. Sanfilippo

claims at least 30 days apart in combination with an anticoagulant prescription within 90 days. 10 The ICD-9-CM codes used in this definition included pulmonary embolism (PE), lower extremity deep vein thrombosis (LE-DVT), and upper extremity DVT (UE

Full access

John A. Glaspy

. Blood 2002 ; 99 : 3978 – 3984 . 61 Wun T Law L Harvey D . Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin . Cancer 2003 ; 98

Full access

John A. Glaspy

. Comparative effectiveness review number 3 . Available at : http://hdl.handle.net/123456789/6875 . Accessed MAy 13, 2008 . 94. Lin A Ryu J Harvey D . Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo

Full access

Alok A. Khorana

events. These can include deep vein thrombosis (DVT), pulmonary embolism (PE), which together are categorized as venous thromboembolism (VTE), and arterial events, including stroke and myocardial infarction. The frequency of both VTE and arterial events